Susquehanna International Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-14,993
| Closed | -$16K | – | 5411 |
|
|
2019
Q1 | $16K | Buy |
+14,993
| New | +$16K | ﹤0.01% | 2860 |
|
|
2018
Q4 | – | Sell |
-51,747
| Closed | -$110K | – | 5597 |
|
|
2018
Q3 | $110K | Buy |
51,747
+37,608
| +266% | +$79.9K | ﹤0.01% | 2931 |
|
|
2018
Q2 | $33K | Sell |
14,139
-74,610
| -84% | -$174K | ﹤0.01% | 3461 |
|
|
2018
Q1 | $282K | Buy |
+88,749
| New | +$282K | ﹤0.01% | 2582 |
|
|
2017
Q3 | – | Sell |
-53,124
| Closed | -$177K | – | 5004 |
|
|
2017
Q2 | $177K | Sell |
53,124
-6,678
| -11% | -$22.3K | ﹤0.01% | 3116 |
|
|
2017
Q1 | $551K | Sell |
59,802
-14,356
| -19% | -$132K | ﹤0.01% | 2176 |
|
|
2016
Q4 | $572K | Buy |
+74,158
| New | +$572K | ﹤0.01% | 2839 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4733 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4839 |
|
|
2016
Q1 | – | Sell |
-35,757
| Closed | -$806K | – | 4974 |
|
|
2015
Q4 | $806K | Buy |
35,757
+6,375
| +22% | +$144K | ﹤0.01% | 2541 |
|
|
2015
Q3 | $487K | Buy |
29,382
+12,197
| +71% | +$202K | ﹤0.01% | 3125 |
|
|
2015
Q2 | $387K | Sell |
17,185
-14,219
| -45% | -$320K | ﹤0.01% | 3566 |
|
|
2015
Q1 | $810K | Buy |
31,404
+12,736
| +68% | +$328K | ﹤0.01% | 2648 |
|
|
2014
Q4 | $406K | Buy |
+18,668
| New | +$406K | ﹤0.01% | 3508 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 4782 |
|